Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery

Annals of Surgical Oncology

Volumn 22, Issue 13, 2015, Pages 4445-4452

  Reisinger, Kostan W ^a,b   Bosmans, Joanna W A M ^a,b   Uittenbogaart, Martine ^c   Alsoumali, Abdulaziz ^a,c   Poeze, Martijn ^a,b   Sosef, Meindert N ^c   Derikx, Joep P M ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS SURGERY; FAT BODY; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; INTESTINE ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; MUSCLE MASS; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RESPIRATORY FAILURE; SARCOPENIC OBESITY; SURGICAL MORTALITY; ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; FOLLOW UP; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOADJUVANT THERAPY; NETHERLANDS; OBESITY, ABDOMINAL; PATHOLOGY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; SARCOPENIA; SKELETAL MUSCLE; SURVIVAL RATE;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MUSCLE, SKELETAL; NEOADJUVANT THERAPY; NEOPLASM STAGING; NETHERLANDS; OBESITY, ABDOMINAL; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; SARCOPENIA; SURVIVAL RATE;

EID: 84947128167     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4558-4     Document Type: Article

References (31)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.
2. Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. JAm Geriatr Soc. 2007;55:769–74.
3. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J GerontolA. 2006;61:1059–64.
4. Reisinger KW, Van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2014;in press.
5. Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012;31:74–7.
6. Lieffers JR, Bathe OF, Fassbender K, et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br JCancer. 2012;107:931–6.
7. van Vledder MG, Levolger S, Ayez N, et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.
8. Tan BH, Birdsell LA, Martin L, et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973–9.
9. Visser M, van Venrooij LM, Vulperhorst L, et al. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis. 2013;23:511–8.
10. Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr. 2014;33:737–48.
11. Spyridaki EC, Simos P, Avgoustinaki PD, et al. The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation. Br J Nutr. 2014;112:1724–34.
12. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.
13. Dello SA, Lodewick TM, van Dam RM, et al. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection. HPB (Oxford). 2013;15:165–9.
14. Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2014.
15. Doyle SL, Bennett AM, Donohoe CL, et al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res. 2013;33:171–9.
16. Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: current management of esophageal cancer. J Gastrointest Surg. 2015.
17. Gockel I, Niebisch S, Ahlbrand CJ, et al. Risk and complication management in esophageal cancer surgery: a review of the literature. Thorac Cardiovasc Surg. 2015.
18. Mendelsohn J. Personalizing oncology: perspectives and prospects. J Clin Oncol. 2013;31:1904–11.
19. Ravasco P, Monteiro-Grillo I, Camilo M. Colorectal cancer: intrinsic characteristics modulate cancer energy expenditure and the risk of cachexia. Cancer Invest. 2007;25:308–14.
20. Bachmann J, Ketterer K, Marsch C, et al. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMCCancer. 2009;9:255.
21. Henneman D, Snijders HS, Fiocco M, et al. Hospital variation in failure to rescue after colorectal cancer surgery: results of the Dutch Surgical Colorectal Audit. Ann SurgOncol. 2013;20:2117–23.
22. Henneman D, van Leersum NJ, Ten Berge M, et al. Failure-to-rescue after colorectal cancer surgery and the association with three structural hospital factors. Ann Surg Oncol. 2013;20:3370–6.
23. Friese CR, Earle CC, Silber JH, et al. Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. Surgery. 2010;147:602–9.
24. Deans DA, Wigmore SJ, de Beaux AC, et al. Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. Br J Surg. 2007;94:1501–8.
25. Martin-Ponce E, Hernandez-Betancor I, Gonzalez-Reimers E, et al. Prognostic value of physical function tests: hand grip strength and six-minute walking test in elderly hospitalized patients. Sci Rep. 2014;4:7530.
26. Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344:e70.
27. Mishra SI, Scherer RW, Snyder C, et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;8:CD008465.
28. Breen L, Phillips SM. Skeletal muscle protein metabolism in the elderly: Interventions to counteract the ‘anabolic resistance’ of ageing. Nutr Metab (Lond). 2011;8:68.
29. Volpi E, Kobayashi H, Sheffield-Moore M, et al. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr. 2003;78:250–8.
30. Oldervoll LM, Loge JH, Paltiel H, et al. The effect of a physical exercise program in palliative care: a phase II study. J Pain Symptom Manag. 2006;31:421–30.
31. Ryan AM, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355–63.